Tat2-Nat

General Information


DRACP ID  DRACP05619

Peptide Name   Tat2-Nat

Sequence  RKKRRQRRRRKKRRQRRR

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Protein derived

Type  Native peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  FITC

C-terminal Modification  Natamycin

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C106H210N60O21

Absent amino acids  ACDEFGHILMNPSTVWY

Common amino acids  R

Mass  296458

Pl  13.54

Basic residues  16

Acidic residues  0

Hydrophobic residues  0

Net charge  16

Boman Index  -21232

Hydrophobicity  -425.56

Aliphatic Index  0

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25467959

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2514

DRACP is developed by Dr.Zheng's team.